John Foote - CardioComm Solutions Director

EKGGF Stock  USD 0.01  0.00  0.00%   

Director

Dr. John Foote, M.D., CCFP ., is Director of the Company since 2017.
Tenure 7 years
Professional MarksPh.D
Phone416 977 9425
Webhttps://www.cardiocommsolutions.com
Foote addition to the BOD as a full voting BOD member and member of the Medical Advisory Committee will be immediate. His role will be to provide current and expert market insights to address best practices for implementation of Cardiocomm arrhythmia monitoring technologies in the family practice and emergency medicine fields as well as for communitybased arrhythmia management strategies. In addition to his current role as a senior emergency room physician and physician influencer, Dr

CardioComm Solutions Management Efficiency

The company has return on total asset (ROA) of 0.164 % which means that it generated a profit of $0.164 on every $100 spent on assets. This is way below average. CardioComm Solutions' management efficiency ratios could be used to measure how well CardioComm Solutions manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 413.81 K in total debt with debt to equity ratio (D/E) of 430.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CardioComm Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, CardioComm Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardioComm Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardioComm to invest in growth at high rates of return. When we think about CardioComm Solutions' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Wai ChowAdvanced Micro Devices
68
Michael InglisAdvanced Micro Devices
58
Damian RocheASE Industrial Holding
N/A
Kenneth HenryASE Industrial Holding
58
Joseph MuscariEnersys
68
Ahmed YahiaAdvanced Micro Devices
45
John CaldwellAdvanced Micro Devices
68
Peter MarriottASE Industrial Holding
59
Rutherford ChangASE Industrial Holding
44
John MarrenAdvanced Micro Devices
55
Raymond LoASE Industrial Holding
64
Peter WarneASE Industrial Holding
60
TienSzu ChenASE Industrial Holding
59
Robert MagnusEnersys
73
John HardingAdvanced Micro Devices
59
Howard HoffenEnersys
57
Ruirong LuoASE Industrial Holding
N/A
MeiYueh HoASE Industrial Holding
69
Sheng YuASE Industrial Holding
N/A
Yasmin AllenASE Industrial Holding
52
Nelda ConnorsEnersys
54
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange. CardioComm Solutions [EKGGF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

CardioComm Solutions Leadership Team

Elected by the shareholders, the CardioComm Solutions' board of directors comprises two types of representatives: CardioComm Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardioComm. The board's role is to monitor CardioComm Solutions' management team and ensure that shareholders' interests are well served. CardioComm Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardioComm Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
Etienne Grima, CEO, Corporate Secretary, Director and Member of Audit Committee
William Smith, Independent Director
Robert Caines, Director
Yury Levin, Independent Director
Anne Burpee, CFO
David Newman, Independent Director
Simi Grosman, Director
Anatoly Langer, Chairman of the Board
John Overall, CFO
Margaret Helms, Director
Josee CPA, Chief Officer
Steven Benyo, Director
MSc CHE, Corp CEO
Simi MBA, Independent Director
John Foote, Director
Wendy Hsieh, CFO

CardioComm Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CardioComm Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CardioComm Solutions

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CardioComm Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CardioComm Solutions will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to CardioComm Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CardioComm Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CardioComm Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CardioComm Solutions to buy it.
The correlation of CardioComm Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CardioComm Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CardioComm Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CardioComm Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in CardioComm Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the CardioComm Solutions information on this page should be used as a complementary analysis to other CardioComm Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for CardioComm Pink Sheet analysis

When running CardioComm Solutions' price analysis, check to measure CardioComm Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioComm Solutions is operating at the current time. Most of CardioComm Solutions' value examination focuses on studying past and present price action to predict the probability of CardioComm Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioComm Solutions' price. Additionally, you may evaluate how the addition of CardioComm Solutions to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Please note, there is a significant difference between CardioComm Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if CardioComm Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CardioComm Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.